UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape

Cell reports (Cambridge), 2016-04, Vol.15 (3), p.481-489

2016

Volltextzugriff (PDF)

HIV drug resistance against strand transfer integrase inhibitors

Retrovirology, 2017-06, Vol.14 (1), p.36-36, Article 36

2017

Volltextzugriff (PDF)

Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance

Virus research, 2017-07, Vol.239, p.1-9

2017

Volltextzugriff (PDF)

Cellular and molecular mechanisms involved in the establishment of HIV-1 latency

Retrovirology, 2013-02, Vol.10 (1), p.11-11, Article 11

2013

Volltextzugriff (PDF)

The role of unintegrated DNA in HIV infection

Retrovirology, 2011-07, Vol.8 (1), p.52-52, Article 52

2011

Volltextzugriff (PDF)

Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir

Journal of Virology, 2012-03, Vol.86 (5), p.2696-2705

2012

Volltextzugriff (PDF)

Early HIV treatment to forestall drug resistance

The Lancet infectious diseases, 2016-05, Vol.16 (5), p.512-513

Wainberg, Mark A

2016

Volltextzugriff (PDF)

Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence

Viruses, 2015-07, Vol.7 (7), p.3703-3718

2015

Volltextzugriff (PDF)

Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication

Scientific reports, 2017-07, Vol.7 (1), p.6345-11, Article 6345

2017

Volltextzugriff (PDF)

Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors

Journal of antimicrobial chemotherapy, 2017-03, Vol.72 (3), p.727-734

2017

Volltextzugriff (PDF)

RIG-I-Mediated Antiviral Signaling Is Inhibited in HIV-1 Infection by a Protease-Mediated Sequestration of RIG-I

Journal of Virology, 2011-02, Vol.85 (3), p.1224-1236

2011

Volltextzugriff (PDF)

Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase

Journal of virology, 2015-03, Vol.89 (6), p.3163-3175

2015

Volltextzugriff (PDF)

Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors

Antimicrobial Agents and Chemotherapy, 2012-10, Vol.56 (10), p.5000-5008

2012

Volltextzugriff (PDF)

Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.1948-1953

2016

Volltextzugriff (PDF)

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

The Journal of infectious diseases, 2007-04, Vol.195 (7), p.951-959

2007

Volltextzugriff (PDF)

Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain

Retrovirology, 2017-10, Vol.14 (1), p.47-47, Article 47

2017

Volltextzugriff (PDF)

Compensation by the E138K Mutation in HIV-1 Reverse Transcriptase for Deficits in Viral Replication Capacity and Enzyme Processivity Associated with the M184I/V Mutations

Journal of Virology, 2011-11, Vol.85 (21), p.11300-11308

2011

Volltextzugriff (PDF)

Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.600-608

2016

Volltextzugriff (PDF)

Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.6223-6235

2013

Volltextzugriff (PDF)

Novel therapeutic strategies targeting HIV integrase

BMC medicine, 2012-04, Vol.10 (1), p.34-34, Article 34

2012

Volltextzugriff (PDF)

The Viral Protein Tat Can Inhibit the Establishment of HIV-1 Latency

Journal of Virology, 2012-03, Vol.86 (6), p.3253-3263

2012

Volltextzugriff (PDF)

Is resistance to dolutegravir possible when this drug is used in first-line therapy?

Viruses, 2014-08, Vol.6 (9), p.3377-3385

2014

Volltextzugriff (PDF)

Tetherin restricts direct cell-to-cell infection of HIV-1

Retrovirology, 2010-12, Vol.7 (1), p.115-115, Article 115

2010

Volltextzugriff (PDF)

Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine

Antimicrobial Agents and Chemotherapy, 2013-07, Vol.57 (7), p.3100-3109

2013

Volltextzugriff (PDF)

Productive Entry of HIV-1 during Cell-to-Cell Transmission via Dynamin-Dependent Endocytosis

Journal of Virology, 2013-07, Vol.87 (14), p.8110-8123

2013

Volltextzugriff (PDF)

1 – 25 von 887

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(809)
Mit Volltextzugriff
(773)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape

HIV drug resistance against strand transfer integrase inhibitors

Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance

Cellular and molecular mechanisms involved in the establishment of HIV-1 latency

The role of unintegrated DNA in HIV infection

Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir

Early HIV treatment to forestall drug resistance

Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence

Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication

Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors

RIG-I-Mediated Antiviral Signaling Is Inhibited in HIV-1 Infection by a Protease-Mediated Sequestration of RIG-I

Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase

Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors

Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain

Compensation by the E138K Mutation in HIV-1 Reverse Transcriptase for Deficits in Viral Replication Capacity and Enzyme Processivity Associated with the M184I/V Mutations

Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase

Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase

Novel therapeutic strategies targeting HIV integrase

The Viral Protein Tat Can Inhibit the Establishment of HIV-1 Latency

Is resistance to dolutegravir possible when this drug is used in first-line therapy?

Tetherin restricts direct cell-to-cell infection of HIV-1

Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine

Productive Entry of HIV-1 during Cell-to-Cell Transmission via Dynamin-Dependent Endocytosis

Suchergebnisse filtern